BFM
HURA

Boothbay Fund Management’s TuHURA Biosciences HURA Stock Holding History

Boothbay Fund Management’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-268
Closed -$403K – 2289
2021
Q3 		$403K Buy
+268
New +$704K 0.01% 1187

Other funds holding HURA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
S
swisspartners Vaduz, Liechtenstein $78.4M AUM 9.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Boothbay Fund Management's HURA Position: Q4 2021 in Review

Boothbay Fund Management sold out of TuHURA Biosciences (HURA) in Q4 2021, closing a stake of 268 shares — an estimated $403K sold.

Boothbay Fund Management first reported a position in HURA in Q3 2021 and held it in 1 quarter. The position peaked at $403K in Q3 2021. 24 funds tracked by Wall St. Rank hold HURA as of Q4 2021.

  • Boothbay Fund Management reported no remaining TuHURA Biosciences position as of Q4 2021 after selling out during the quarter.
  • Boothbay Fund Management sold 268 TuHURA Biosciences shares in Q4 2021, an estimated $403K.
  • Boothbay Fund Management first reported a position in TuHURA Biosciences in Q3 2021 and held it in 1 quarter.
  • Boothbay Fund Management's TuHURA Biosciences position peaked at $403K in Q3 2021.
  • 24 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q4 2021.

Based on Boothbay Fund Management's 13F filing for Q4 2021, filed 14 Feb 2022.